Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Daridorexant Atc N05Cj03 For The Period June 1St 2026 May 31St 2028

Deadline: 05 Apr 2028

Germany

Ref. No.: 26734602

EMD:Ref Document

Bid Value: Ref Document

508 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Clobazam Excl Dafo Sue Atc N05Ba09 For The Period June 1St 2026 May 31St 2028 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734578

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Clobazam Excl Dafo Tab Atc N05Ba09 For The Period June 1St 2026 May 31St 2028 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734575

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pomalidomide Excl 1Mg 2Mg Pkg 14St Atc L04Ax06 For The Period 1 6 26 31 5 28 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734558

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Ws Bimatoprost Exclusively In The Effective Strength 0 1 Mg Ml Atc S01Ee03 F D Z 01 6 26 31 5 28 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734555

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Gentamicin Atc S01Aa11 For The Period June 1St 2026 May 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734544

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tianeptine Atc N06Ax14 For The Period June 1St 2026 May 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734533

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Prednicarbate Atc D07Ac18 For The Period June 1St 2026 May 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734519

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Piperacillin Tazobactam Atc J01Cr05 For The Period June 1St 2026 May 31St 2028 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734513

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Methylprednisolone Atc D07Ac14 For The Period June 1St 2026 May 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734509

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dalbavancin Atc J01Xa04 For The Period June 1St 2026 May 31St 2028 Plus Extension Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734503

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Mesalazine Excl Dafo Tmr Atc A07Ec02 For The Period June 1St 2026 May 31St 2028 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734499

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Mesalazine Excl Dafo Rsu Kli Atc A07Ec02 For The Period 06 01 26 05 31 28 Plus V Option 1X12 Months

Deadline: 05 Apr 2029

Germany

Ref. No.: 26734495

EMD:Ref Document

Bid Value: Ref Document

873 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dolutegravir Atc J05Aj03 For The Period June 1St 2026 May 31St 2028

Deadline: 05 Apr 2028

Germany

Ref. No.: 26734490

EMD:Ref Document

Bid Value: Ref Document

508 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Trastuzumab Exclusively 600 Mg I E D Atc L01Fd01 For The Period June 1 2026 May 31 2028

Deadline: 05 Apr 2028

Germany

Ref. No.: 26734485

EMD:Ref Document

Bid Value: Ref Document

508 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!